Search Results - "Kaale, Eliangiringa A"

A high-performance thin-layer chromatography densitometric method for the separation of isomeric ceftriaxone in powder for injection formulation by Mwamwitwa, Kissa W., Nyamweru, Bugusu, Iwodyah, Mohamed A., Sambu, Gerald, Nyondo, Goodluck G., Yondu, Emili, Fimbo, Adam M., Manyanga, Vicky, Sabiiti, Wilber, Shewiyo, Danstan H., Shearer, Morven C., Smith, Andrew D., Kaale, Eliangiringa A.

“…The aim of this study was to develop and validate a High-Performance Thin Layer Chromatographic (HPTLC) method for simultaneous determination of ceftriaxone…”
Get full text

Effectiveness of a structured stimulated spontaneous safety monitoring of medicines reporting program in strengthening pharmacovigilance system in Tanzania by Mwamwitwa, Kissa W., Fimbo, Adam M., Bukundi, Elias M., Nkayamba, Alex F., Buma, Deus, Muro, Eva P., Maganda, Betty A., Shewiyo, Danstan H., Shearer, Morven C., Smith, Andrew D., Kaale, Eliangiringa A.

“…Under-reporting of adverse drug events (ADEs) is a challenge facing developing countries including Tanzania. Given the high magnitude of under-reporting, it…”
Get full text

Conformity of package inserts information to regulatory requirements among selected branded and generic medicinal products circulating on the East African market by Sillo, Hiiti B, Masota, Nelson E, Kisoma, Sunday, Rago, Lembit, Mgoyela, Veronica, Kaale, Eliangiringa A

“…Availability of correct and adequate information about medicines is an important aspect in ensuring rational use of medicines and hence facilitating safety and…”
Get full text

Adverse Drug Reactions Resulting From the Use of Chiral Medicines Amoxicillin, Amoxicillin-Clavulanic Acid, and Ceftriaxone: A Mixed Prospective-Retrospective Cohort Study by Mwamwitwa, Kissa W, Bukundi, Elias M, Maganda, Betty A, Munishi, Castory, Fimbo, Adam M, Buma, Deus, Muro, Eva P, Sabiiti, Wilber, Shewiyo, Danstan H, Shearer, Morven C, Smith, Andrew D, Kaale, Eliangiringa A

“…The use of chiral medicines (possessing center(s) of asymmetric carbon) may cause adverse drug reactions (ADRs). The safety assurance of these medicines is…”
Get full text

A retrospective cross-sectional study to determine chirality status of registered medicines in Tanzania by Mwamwitwa, Kissa W., Kaibere, Raphael M., Fimbo, Adam M., Sabitii, Wilber, Ntinginya, Nyanda E., Mmbaga, Blandina T., Shewiyo, Danstan H., Shearer, Morven C., Smith, Andrew D., Kaale, Eliangiringa A.

“…Medicines with a stereogenic center (asymmetric carbon) are mainly present as racemates with a mixture of equal amounts of enantiomers. One enantiomer may be…”
Get full text

Economic cost of substandard and falsified human medicines and cosmetics with banned ingredients in Tanzania from 2005 to 2015: a retrospective review of data from the regulatory authority by Mori, Amani Thomas, Meena, Estella, Kaale, Eliangiringa A

“…ObjectiveTo estimate the economic cost of substandard and falsified human medicines and cosmetics with banned ingredients in Tanzania from 2005 to 2015.DesignA…”
Get full text

Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: evaluation against the accountability for reasonableness framework by Mori, Amani Thomas, Kaale, Eliangiringa Amos

“…Priority setting for artemisinin-based antimalarial drugs has become an integral part of malaria treatment policy change in malaria-endemic countries. Although…”
Get full text